PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBAug 16, 2024 | Webinars. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase. Addressing these challenges early is crucial ...
Novo Nordisk announces positive phase 2 trial results for type 2 ...
WEBAug 23, 2022 · Commenting on the positive results, Martin Holst Lange, executive vice president for development at Novo Nordisk, said: “We are encouraged by the impressive phase 2 results for CagriSema in people with type 2 diabetes. The results indicate that CagriSema reduces blood sugar more than semaglutide alone and …
FDA approves BMS’s Opdualag for metastatic or unresectable
WEBMar 23, 2022 · Bristol Myers Squibb (BMS) has announced that Opdualag (nivolumab and relatlimab-rmbw) has received approval from the US Food and Drug Administration (FDA) for the treatment of adult and paediatric patients aged 12 years or older with metastatic melanoma or melanoma which cannot be treated with …
Communiqué 2023: a celebration of excellence in healthcare ...
WEBJul 7, 2023 · The Communiqué Awards returned for its 25th year to celebrate excellence within the healthcare communications industry.. Held at the London Grosvenor House Hotel on 6 July, the event welcomed hundreds of guests who were dressed in smart evening wear and excited to show their support for their respective companies.
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.
Eli Lilly increases investment to almost $1bn for new Irish ...
WEBMar 29, 2023 · Eli Lilly has said it will be doubling the planned investment in its new biologics manufacturing facility in Ireland, bringing the total spend up to almost $1bn. The company originally announced its plans to build the Limerick-based facility in January 2022, which it anticipates will be its ‘most technically advanced manufacturing site to ...
2023 PM Society Awards – winners announced - PMLiVE
WEB2023 PM Society Awards – winners announced. The PM Society’s 37th annual awards was held on 17 March 2023 at the JW Marriott Grosvenor House London when the industry came together to celebrate the best creative communications in pharma and healthcare. PM Society Co-Chair Caroline Benson kicked off the afternoon, with charity Duchenne UK ...
Pfizer helps fund biotech venture from former researchers at …
WEBNov 5, 2012 · Pfizer is to help fund research by Ziarco, a recently launch UK biotech headed by a scientist formerly at Pfizer’s research centre in Kent, UK. Ziarco’s CEO Dr Mike Yeadon was chief scientific officer, allergy and respiratory research, during his time at Pfizer, before the US pharma firm announced last year it would leave the facility.
Sobi and Apellis’ pegcetacoplan shows promise in phase 3 rare …
WEBAug 14, 2024 · Sobi and Apellis Pharmaceuticals have shared positive late-stage results for their targeted C3 therapy in rare kidney disease patients. The phase 3 VALIANT trial has been evaluating the drug, pegcetacoplan, in patients with C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).
Keytruda gains eighth FDA approval this year - PMLiVE
WEBDec 7, 2021 · 2021 has been a good year for Keytruda (pembrolizumab), which has notched up more than 20 approvals across the world and is on track to bring in at least £17bn for Merck – known as MSD outside the US and Canada – this year alone.